KR20010025824A - Cosmetic compositions for the skin having pimples thereon - Google Patents

Cosmetic compositions for the skin having pimples thereon Download PDF

Info

Publication number
KR20010025824A
KR20010025824A KR1019990036863A KR19990036863A KR20010025824A KR 20010025824 A KR20010025824 A KR 20010025824A KR 1019990036863 A KR1019990036863 A KR 1019990036863A KR 19990036863 A KR19990036863 A KR 19990036863A KR 20010025824 A KR20010025824 A KR 20010025824A
Authority
KR
South Korea
Prior art keywords
skin
acne
indole
acid
weeks
Prior art date
Application number
KR1019990036863A
Other languages
Korean (ko)
Inventor
이헌진
황정웅
문재철
Original Assignee
이경수
코스맥스 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이경수, 코스맥스 주식회사 filed Critical 이경수
Priority to KR1019990036863A priority Critical patent/KR20010025824A/en
Publication of KR20010025824A publication Critical patent/KR20010025824A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/008Preparations for oily skin

Abstract

PURPOSE: A cosmetic composition for acne skin is provided, which inhibits secretion of sebum without skin irritation, and improves keratinized skin due to acne by containing indole-3 complex composed of indole-3 acetic acid(formula), carbamide peroxide and α-hydroxy acid(AHA). CONSTITUTION: The cosmetic composition for acne skin is comprised of distilled water, 1.0-8.0 wt.% of glycerin, 1.0-8.0 wt.% of 1,3-butylene glycol, 0.05-0.2 wt.% of allantoin, 3.0-10.0 wt.% of ethanol, 0.01-0.2 wt.% of disodium ethylenediaminetetraacetate, 0.01-0.1 wt.% of carboxyvinylcellulose, 0.000 1-0.01 wt% of sodium hydroxide, 5.0-15.0 wt% of carbamide peroxide(which decreases bacteria by removing keratins), 0.0001-0.1 wt% of indole-3 acetic acid(which regenerates wounded skin), 0.2-1.0 wt% of α-hydroxy acid(AHA; which shows keratin-softening effect and moisturizing effect, cell-regeneration effect, wound-treatment effect), 0.02wt.% of paraoxybenzoic ester. The cosmetic composition for acne skin can be prepared into a gel or an emulsion type.

Description

여드름 피부용 화장료 조성물{Cosmetic compositions for the skin having pimples thereon}Cosmetic compositions for acne skin {Cosmetic compositions for the skin having pimples thereon}

본 발명은 여드름 피부용 화장료 조성물에 관한 것으로, 더욱 상세하게는 인돌-3 아세틱애시드, 카바마이드 퍼옥사이드 및 α-히드록시 애시드로 이루어진 인돌-3 복합체(Indole-3 complex)를 함유하여 피부에 대한 자극없이, 피지의 분비를 억제하고, 여드름에 의해 각화된 피부를 개선시킬 수 있는 여드름 피부용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for acne skin, and more particularly to the skin containing the indole-3 complex (Indole-3 complex) consisting of indole-3 acetic acid, carbamide peroxide and α-hydroxy acid The present invention relates to a cosmetic composition for acne skin, which can suppress sebum secretion and improve skin agglomerated by acne.

여드름 좌창(Acne vulgaris)은 피부의 돌출로 나타나는 모선(毛腺: pilosebaceous gland)에 염증을 유발하는 병으로 자연적으로는 오돌도돌하지만 화농하지 만은 않다. 여드름은 사춘기의 공통적인 고민거리이며, 성인들도 여드름으로 고민하는 사람이 상당수가 있다. 이러한 여드름 좌장에는 면포반(Comedones: blackheads or whiteheads), 구진(丘疹: papules), 농포(膿胞) 및 낭포(囊胞: cysts or nodules)의 네가지 유형이 있는데, 황, 레소르치놀, 살리실산, 벤조일 퍼옥사이드, 비타민 A, 카바마이드 퍼옥사이드, 항생제 등을 함유하는 다양한 제제들이 이들의 치료에 사용되고 있다.Acne vulgaris is a disease that causes inflammation of the pilosebaceous gland, which is a protrusion of the skin, and is naturally absurd but not purulent. Acne is a common problem in puberty, and many adults also suffer from acne. There are four types of acne seats: comedones (blackheads or whiteheads), papules, pustules, and cysts or nodules (sulfur, resorcinol, salicylic acid, Various preparations containing benzoyl peroxide, vitamin A, carbamide peroxide, antibiotics and the like are used for their treatment.

그러나, 상기한 제제를 함유하는 여드름 치료용 제제는 여드름 치료에는 어느정도 성과를 거두고 있으나, 효과적인 면이나 부작용 측면에서 몇가지 문제점들을 가지고 있다.However, the acne-containing formulations containing the above-described preparations have some results in the treatment of acne, but have some problems in terms of effectiveness and side effects.

즉, 레소르치놀은 1~2의 농도로 소량 사용되는데, 약간 어두운 피부를 한 사람들에게 암갈색 딱지를 형성시키는 문제점이 있고, 테트라사이클린을 위시한 항생물질은 내성균의 출혈 및 광과민작용의 가능성이 있는 문제점이 있다.In other words, resorcinol is used in a small amount at a concentration of 1 to 2, there is a problem of forming a dark brown scab in people with slightly dark skin, and tetracycline-containing antibiotics have the potential of bleeding and photosensitization of resistant bacteria There is this.

한편, 벤조일퍼옥사이드는 여드름에 이용될 수 있는 가장 효과적인 물질임에도 불구하고, 독성이 있으며, 종기를 촉발시키고, 극단의 건조함, 가려움, 피부자극, 홍반, 피부의 벗겨짐이나 붓는 현상들이 나타나는 문제점이 있다.On the other hand, although benzoyl peroxide is the most effective substance that can be used for acne, it is toxic, triggers boils, causes extreme dryness, itching, skin irritation, erythema, peeling or swelling of skin. have.

이에, 본 발명자들은 종래 여드름 치료에 사용되던 성분들이 갖는 상기한 문제점을 유발하지 않으면서, 피지의 분비를 억제할 수 있고, 여드름에 의해 각화된 피부를 개선시킬 수 있는 화장료 조성물을 제공하고자 연구를 거듭한 결과, 상기한 목적을 달성할 수 있음을 발견하고 본 발명을 완성하게 되었다.Accordingly, the present inventors have studied to provide a cosmetic composition that can suppress the secretion of sebum and improve the skin aggravated by acne without causing the above problems with the components used in conventional acne treatment. As a result, it has been found that the above object can be achieved and the present invention has been completed.

따라서, 본 발명의 목적은 피부에 대한 자극이 없으면서, 피지의 분비를 억제하고, 여드름에 의해 각화된 피부를 개선시킬 수 있는 여드름 피부용 화장료 조성물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a cosmetic composition for acne skin that can suppress sebum secretion and improve skin aggravated by acne without irritation to the skin.

상기한 목적을 달성하기 위하여, 본 발명에 따른 화장료 조성물은 조성물 총중량에 대하여 인돌-3 아세트에시드 0.0001~0.01중량, 카바마이드 퍼옥사이드 5.0~15.0중량및 α-히드록시 애시드 0.2~1.0중량를 함유하는 것을 특징으로 한다.In order to achieve the above object, the cosmetic composition according to the present invention contains 0.0001 to 0.01 weight of indole-3 acetoxide, 5.0 to 15.0 weight of carbamide peroxide and 0.2 to 1.0 weight of α-hydroxy acid based on the total weight of the composition It features.

이하, 본 발명을 보다 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail.

본 발명의 여드름 피부용 화장료 조성물은 인돌-3 아세틱애시드, 카바마이드 퍼옥사이드 및 α-히드록시애시드를 함유하는 것에 의해 피부자극 없이 여드름을 개선시킬 수 있다. 더구나, 본 발명의 조성물은 여드름에 의해 각화된 피부를 개선시킬 수 있다.The cosmetic composition for acne skin of the present invention can improve acne without skin irritation by containing indole-3 acetic acid, carbamide peroxide and α-hydroxyacid. Moreover, the composition of the present invention can improve skin aroused by acne.

본 발명에서 사용된 인돌-3 아세틱애시드는 하기 일반식(Ⅰ)으로 표시되는 화합물로서 종래 식물성장호르몬으로 사용되었으나, 본 발명에서는 화장품에 함유되어 피부에 도포 되었을 때 빠르게 세포들이 없는 지역으로 건강한 인간의 섬유아세포들을 이동시키는 작용을 한다. 따라서, 이주된 건강한 세포는 밀도가 낮은 공간을 효과적으로 채우는 것에 따라 세포의 정상속도에서 그때 분열할 수 있으므로, 상처 치료나 피부를 성장시키게 하고 결국, 여드름에 의해 각질화된 피부를 개선시키는 것이다.Indole-3 acetic acid used in the present invention was used as a conventional plant growth hormone as a compound represented by the following general formula (I), but in the present invention, when it is contained in cosmetics and applied to the skin, it is rapidly moved to an area without cells. It acts to move human fibroblasts. Thus, the migrated healthy cells can then divide at the normal rate of the cells as they effectively fill the low density space, thereby causing wound healing or skin growth and eventually improving skin exfoliated by acne.

(Ⅰ) (Ⅰ)

본 발명에서 인돌-3 아세틱애시드는 화장료 총 중량에 대하여 0.0001~0.1중량의 양으로 사용한다.Indole-3 acetic acid in the present invention is used in an amount of 0.0001 ~ 0.1 weight based on the total weight of the cosmetic.

또한, 본 발명에서 사용된 카바마이드 퍼옥사이드는 여드름을 야기시키는 박테리아를 각질제거로 감소시켜주고, 피부에 있는 에스테르나 지방산들을 건조시키는 것에 의해 여드름 치료에 사용될 수 있음이 알려져 있지만, 단독으로 작용한다면 여드름을 치료하는데 있어 벤조일퍼옥사이드 만큼 효과를 나타내지는 않는다. 그러나, 본 발명에서는 인돌-3 아세틱애시드 및 α-히드록시애시드와 함께 사용하는 것에 의해 상승효과를 갖는다. 카바마이드 퍼옥사이드의 사용량은 조성물 총 중량에 대하여 5.0~15.0중량이다.In addition, the carbamide peroxide used in the present invention is known to be used in the treatment of acne by reducing the bacteria causing acne by exfoliation and drying the esters or fatty acids in the skin, It is not as effective as benzoyl peroxide in treating acne. However, in the present invention, synergistic effect is obtained by use with indole-3 acetic acid and α-hydroxyacid. The amount of carbamide peroxide used is 5.0-15.0 weight based on the total weight of the composition.

또한, 본 발명에서 사용된 α-히드록시애시드(이하 'AHA'라 한다)는 각질유연 및 보습효과, 각질박리촉진효과, 세포재생효과, 각질의 턴오브 주기 감소효과, 각질층 두께감소효과, 상처치유효과 등의 효과가 공지되어 있는 물질로 화장료에 사용하여 상기한 효과를 나타내기 위해서는 상당량을 사용하여야 하는데, 이 경우, 알파히드록시산은 분자량이 작아 피부로의 침투가 쉽기 때문에 피부자극을 유발시키는 문제가 있어, 그 사용량이 제한되고 있다. 그러나, 본 발명에서는 상기 인돌-3 아세틱애시드와 카바마이드 퍼옥사이드와 혼용하여 사용하므로 소량 사용하여도 AHA가 효과를 제공할 수 있다. AHA의 사용량은 조성물 총 중량에 대하여 0.2~1.0중량이다.In addition, the α-hydroxy acid (hereinafter referred to as 'AHA') used in the present invention is keratin softening and moisturizing effect, keratin exfoliation effect, cell regeneration effect, keratin turn-off cycle reduction effect, keratin layer thickness reduction effect, wound In order to achieve the above-mentioned effects by using cosmetics as a substance with known effects such as healing effects, in this case, alpha hydroxy acid has a small molecular weight and is easy to penetrate into the skin, causing skin irritation. There is a problem and its usage is limited. However, in the present invention, since the indole-3 acetic acid and the carbamide peroxide are used in combination, AHA may provide an effect even in a small amount. The amount of AHA used is 0.2 to 1.0 weight based on the total weight of the composition.

본 발명에서 사용된 AHA의 종류는 특별히 한정되지 않지만, 글리콜산, 젖산, 능금산, 유산, 주석산, 구연산, 글리세릭산, 글루쿠론산, 타트론닉산, 만데릭산, 아스코르빅산, 피루빅산 등 인공적으로 합성되어진 AHA 및 자연적으로 생성된 AHA들 중 1종 이상을 사용한다.Although the type of AHA used in the present invention is not particularly limited, glycolic acid, lactic acid, nitric acid, lactic acid, tartaric acid, citric acid, glyceric acid, glucuronic acid, tatronic acid, manderic acid, ascorbic acid, pyruvic acid and the like Artificially synthesized AHAs and one or more of naturally produced AHAs are used.

상기한 성분들을 함유하는 본 발명의 화장료 조성물은 1.0~8.0중량의 글리세린, 1.0~8.0중량의 1,3-부틸렌글리콜, 0.05~0.2중량의 알라토인, 3.0~10.0중량의 에탄올, 0.01~0.1중량의 카르복시셀룰로오스, 0.01~0.2중량의 에틸렌디아민데트라초산디나트륨, 0.0001~0.01중량의 수산화 나트륨을함유하여 겔로 제형화될 수 있으며, 또한, 유화형태로 제형화될 수도 있다. 각 제형에 있어서, 상기한 세가지 유효성분이외에 피부에 대한 이로운 효능들이 입증되어진 다른 성분들을 더 함유할 수도 있다. 예를 들면, 알란토인(allantoin)은 항염증치료제로서 작용하도록 처방되어질 수 있고, 살리실산은 보조적인 여드름 치료 성분으로써 첨가되어질 수 있다. 기타 다른 성분들은 화장료 제형에 따라 당업자가 적의하게 선정하여 배합한다.Cosmetic composition of the present invention containing the above components is 1.0 to 8.0 weight of glycerin, 1.0 to 8.0 weight of 1,3-butylene glycol, 0.05 to 0.2 weight of allatoin, 3.0 to 10.0 weight of ethanol, 0.01 to 0.1 It may be formulated into a gel with a weight of carboxycellulose, 0.01 to 0.2 weight of ethylenediaminedetraacetic acid disodium, 0.0001 to 0.01 weight of sodium hydroxide, and may also be formulated in an emulsified form. In each formulation, in addition to the three active ingredients described above, it may further contain other ingredients that have proven beneficial effects on the skin. For example, allantoin may be prescribed to act as an anti-inflammatory agent and salicylic acid may be added as a supplemental acne treatment ingredient. The other ingredients are appropriately selected and blended by those skilled in the art according to the cosmetic formulation.

이하, 실시예를 들어 본 발명을 상세히 설명하지만, 본 발명이 이들예로만 한정되는 것은 아니다Hereinafter, although an Example is given and this invention is demonstrated in detail, this invention is not limited only to these examples.

원 료 명Raw material name 실시예 1Example 1 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 정제수글리세린1,3-부틸렌 글리콜알란토인에탄올살리실산파라옥시안식향산에스텔에틸렌디아민테트라초산디나트륨카르복시 비닐셀루로즈수산화 나트륨카바마이드 퍼옥사이드인돌-3 아세틱애시드α-히드록시애시드벤조일 퍼옥사이드Purified water Glycerin 1,3-butylene glycol Alantoin Ethanol Salicylic acid Paraoxybenzoic acid Ethylene ethylene diamine Tetra acetate disodium Carboxy vinyl cellulose Rhodium hydroxide Carbamide peroxide Indole-3 Acetic acid α-hydroxy acid benzoyl peroxide 75.1695.05.00.14.0-0.20.020.150.00110.00.010.35-75.1695.05.00.14.0-0.20.020.150.00110.00.010.35- 74.6695.05.00.14.00.50.20.020.150.00110.00.010.35-74.6695.05.00.14.00.50.20.020.150.00110.00.010.35- 84.6695.05.00.14.00.50.20.020.150.001-0.010.35-84.6695.05.00.14.00.50.20.020.150.001-0.010.35- 75.035.05.00.14.00.50.20.020.15----10.075.035.05.00.14.00.50.20.020.15 ---- 10.0 *α-히드록시애시드: 젖산, 주석산 및 구연산의 혼합물α-hydroxyacid: a mixture of lactic acid, tartaric acid and citric acid

<시험예 1> 여드름 감소 효과<Test Example 1> acne reduction effect

상기 실시예 1 및 비교예 1~3의 겔을 가지고 여드름 감소효과를 측정하였다. 측정방법은 16~37세의 여성 3명과 남성 2명에게 각각의 겔을 사용하였을 때 및 사용하지 않았을 때, 시간의 경과에 따른 여드름 정도를 하기 평가기준에 따라 평가하도록 한 후, 그 결과를 표 1 내지 표 4에 나타내었다.Acne reduction effect was measured with the gel of Example 1 and Comparative Examples 1 to 3. The measurement method was to evaluate the degree of acne over time according to the following evaluation criteria when three gels of 16 to 37 years old and two men of each gel were used and not used. 1 to Table 4 are shown.

<평가기준><Evaluation Criteria>

점수score 여 드 름 현 상Icicle phenomenon 123451 2 3 4 5 Whiteheads가 뚜렷이 있는 여드름 면포반구진(丘疹)이 뚜렷한 구진성 여드름농포(Pustules)와 난포(Follicles)에 구진에 감염이 뚜렷한 농포성여드름여드름이 각질층 밑으로 확대된 구형체로 커진 상태의 낭포성여드름이나 원구형의 여드름.여드름에 감염된 후 일반적인 2 차적 형성, 여드름 흉터가 남는다.Acne scalp hemiform with clear whiteheads Acicular pustules and follicles (Follicles) with acicular acne that is clearly infected with papules Acne with enlarged globular acne with globular acne Spherical acne, after the infection of the acne, the general secondary formation, acne scars remain.

실시예 1Example 1 피시험자Subject 처 리process 처리 안함Do not process 처리 전Before treatment 2주2 weeks 4주4 Weeks 6주6 Weeks 처리 전Before treatment 2주2 weeks 4주4 Weeks 6주6 Weeks 1One 2.02.0 2.02.0 1.01.0 0.00.0 2.02.0 2.02.0 2.02.0 2.02.0 22 3.03.0 3.03.0 2.02.0 1.01.0 3.03.0 3.03.0 3.03.0 3.03.0 33 2.02.0 2.02.0 1.01.0 0.00.0 2.02.0 2.02.0 2.02.0 2.02.0 44 1.01.0 1.01.0 0.00.0 0.00.0 1.01.0 1.01.0 1.01.0 1.01.0 55 1.01.0 1.01.0 0.00.0 0.00.0 1.01.0 1.01.0 1.01.0 1.01.0 평균Average 1.81.8 1.81.8 0.80.8 0.20.2 1.81.8 1.81.8 1.81.8 1.81.8 0.00.0 -55.6-55.6 -88.9-88.9

비교예 1Comparative Example 1 피시험자Subject 처 리process 처리 안함Do not process 처리 전Before treatment 2주2 weeks 4주4 Weeks 6주6 Weeks 처리 전Before treatment 2주2 weeks 4주4 Weeks 6주6 Weeks 1One 3.03.0 2.02.0 1.01.0 1.01.0 3.03.0 3.03.0 3.03.0 3.03.0 22 2.02.0 1.01.0 1.01.0 1.01.0 2.02.0 2.02.0 2.02.0 2.02.0 33 2.02.0 1.01.0 1.01.0 1.01.0 2.02.0 2.02.0 2.02.0 2.02.0 44 2.02.0 2.02.0 1.91.9 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 55 3.03.0 3.03.0 2.02.0 2.02.0 3.03.0 3.03.0 3.03.0 3.03.0 평균Average 2.42.4 1.81.8 1.21.2 1.21.2 2.22.2 2.22.2 2.22.2 2,22,2 -25.0-25.0 -50.0-50.0 -50.0-50.0

비교예 2Comparative Example 2 피시험자Subject 처 리process 처리 안함Do not process 처리 전Before treatment 2주2 weeks 4주4 Weeks 6주6 Weeks 처리 전Before treatment 2주2 weeks 4주4 Weeks 6주6 Weeks 1One 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 22 3.03.0 3.03.0 3.03.0 2.02.0 3.03.0 3.03.0 3.03.0 3.03.0 33 2.02.0 2.02.0 3.03.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 44 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 55 1.01.0 1.01.0 1.01.0 0.00.0 1.01.0 1.01.0 1.01.0 1.01.0 평균Average 2.02.0 2.02.0 2.02.0 1.61.6 2.02.0 2.02.0 2.02.0 2.02.0 0.00.0 0.00.0 -20.0-20.0

비교예 3Comparative Example 3 피시험자Subject 처 리process 처리 안함Do not process 처리 전Before treatment 2주2 weeks 4주4 Weeks 6주6 Weeks 처리 전Before treatment 2주2 weeks 4주4 Weeks 6주6 Weeks 1One 2.02.0 2.02.0 1.01.0 1.01.0 2.02.0 2.02.0 2.02.0 2.02.0 22 2.02.0 2.02.0 1.01.0 1.01.0 2.02.0 2.02.0 2.02.0 2.02.0 33 2.02.0 2.02.0 1.01.0 1.01.0 2.02.0 2.02.0 2.02.0 2.02.0 44 2.02.0 2.02.0 1.01.0 0.00.0 2.02.0 2.02.0 2.02.0 2.02.0 55 2.02.0 2.02.0 1.01.0 1.01.0 2.02.0 2.02.0 2.02.0 2.02.0 평균Average 2.02.0 2.02.0 1.01.0 0.80.8 2.02.0 2.02.0 2.02.0 2.02.0 0.00.0 -50.0-50.0 -60.0-60.0

상기 표 1 내지 4로부터, 본 발명의 화장료는 벤조일 퍼옥사이드를 단독으로 함유하는 비교예 3보다 그 효과가 우수하다는 것을 알 수 있다. 한편, 인돌-3 아세틱산과 AHA만을 함유하는 경우(비교예 2), 그 효과가 본 발명과 비교하여 매우 작음을 알 수 있으며, 본 발명의 화장료에 각질박리기능 및 살균기능이 우수한 것으로 공지된 살리실산을 화장료에 첨가할 수 있는 최대량(0.5중량)으로 더 첨가한 경우(비교예 1)에는 여드름 치유효과가 빠르게 나타나기는 하지만 전체적인 효과는 본 발명의 화장료가 더 우수하다는 것을 알 수 있다.From Tables 1 to 4, it can be seen that the cosmetic of the present invention is superior in the effect than Comparative Example 3 containing benzoyl peroxide alone. On the other hand, in the case of containing only indole-3 acetic acid and AHA (Comparative Example 2), it can be seen that the effect is very small compared to the present invention, it is known that the exfoliation function and sterilization function excellent in the cosmetic of the present invention When the salicylic acid is further added in the maximum amount (0.5 weight) that can be added to the cosmetic (Comparative Example 1), although the acne healing effect appears quickly, the overall effect can be seen that the cosmetic of the present invention is better.

<시험예 2> 피부자극 평가<Test Example 2> Skin irritation evaluation

상기 실시예 1 및 비교예 1~3의 겔을 각각의 첩보 시험용 핀챔버에 묻혀 집단 1∼4의 19명을 대상으로 팔 하복부 안쪽에 48시간 동안 테이프로 고정시킨 후, 핀챔버를 제거하고 2시간 경과 후의 결과를 판정하였다. 판정은 하기의 육안판정 기준에 의거하여 수행하였으며, 하기 수학식 1에의거하여 자극도를 계산하여 그 결과를 결과는 표 7에 나타내었다.The gels of Examples 1 and Comparative Examples 1 to 3 were buried in the respective intelligence test pin chambers, and then fixed to the inside of the lower abdomen for 48 hours with tapes for 19 people in groups 1 to 4, and then the pin chambers were removed. The result after time passed was determined. The determination was performed based on the following visual judgment criteria, and the stimulus degree was calculated based on Equation 1 below, and the results are shown in Table 7.

<육안 판정 기준><Visual judgment standard>

+홍반정도+ Erythema 기호sign 비고Remarks 가중치weight 부작용 없음의양성약양성중양성강양성No side effects Positive drug positive Positive positive positive -+-++++++-+-++++++ 홍반 없음주변보다 약간 붉은 듯함1/3이상 붉은 증상붉은색 완연붉은 수포 및 갈변, 인설부종 동반No erythema Appears slightly reddish than the surroundings Redness more than 1/3 Reddish symptom Reddish blister and browning, accompanied by swelling 0123401234

<피부 자극 기준><Skin irritation standard>

자극도Stimulus 판정내용Judgment 0~0.20.21~0.50.51~1.251.26이상0 ~ 0.20.21 ~ 0.50.51 ~ 1.251.26 or more 자극이 전혀 없음미미한 자극보통 자극심한 자극No irritation at all

피 시험자Blood tester 실시예 1Example 1 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 집단1Group1 1One -- -- -- -- 22 -- -- -- +-+- 33 +-+- +-+- -- ++ 44 -- -- -- +-+- 55 -- -- -- -- 집단2Group2 1One -- -- -- +-+- 22 -- -- -- +-+- 33 -- -- -- +-+- 44 +-+- -- +-+- ++ 55 -- -- -- +-+- 집단3Group3 1One +-+- +-+- -- +-+- 22 -- -- -- -- 33 -- -- -- +-+- 44 -- +-+- -- -- 55 -- -- -- +-+- 집단4Group 4 22 -- -- -- -- 33 -- -- -- -- 44 -- +-+- -- +-+- 55 -- -- -- -- 자극도Stimulus 0.150.15 0.210.21 0.050.05 0.730.73

상기 표 7로부터, 본 발명의 화장료는 벤조일 퍼옥사이드를 함유하는 화장료가 자극을 나타내는데 반해, 자극이 전혀 나타나지 않는다는 것을 알 수 있다.From the above Table 7, it can be seen that the cosmetic of the present invention exhibits irritation while the cosmetic containing benzoyl peroxide exhibits no stimulus.

<시험예 3> 피지유분량 측정<Test Example 3> Sebum oil amount measurement

실시예 1의 겔에 대한 피지제거 효능을 측정하였다. 피지측정 방법은 집단 1, 2의 대상자를 통해 피부유분량을 Sebummeter SM410 (Courage and Khazaka, Germany)를 이용하여 측정하였다. 측정은 투명 플라스틱 필름이 부착되는 Probe를 피부 표면에 접촉하여 피지를 흡착 한 후 빛이 투과하는 정도를 측정하였으며, 측정치는 임의 단위인 Arbitrary unit(AU)으로 표시하였다. 그 결과를 표 8이 나타내었다.The sebum removal efficacy on the gel of Example 1 was measured. In the sebum measurement method, skin fractions were measured by subjects in groups 1 and 2 using Sebummeter SM410 (Courage and Khazaka, Germany). The measurement was performed to measure the extent of light transmission after adsorbing sebum by contacting the surface of the probe with the transparent plastic film and adsorbing sebum. The results are shown in Table 8.

화장료 처리 전Before cosmetic treatment 화장료 처리 4주 후4 weeks after cosmetic treatment 이마forehead 빰(볼)볼 (ball) 이마forehead 빰(볼)볼 (ball) 집단1Group1 1(남)1 (male) 88.6588.65 37.2937.29 84.8684.86 33.8633.86 2(남)2 (male) 86.7486.74 35.6535.65 85.0485.04 34.6734.67 33 54.4554.45 16.0916.09 53.0753.07 15.815.8 44 54.2154.21 17.5317.53 52.7552.75 16.7816.78 55 53.9753.97 15.9815.98 51.9851.98 15.0815.08 집단2Group2 1One 54.6754.67 15.7815.78 53.1253.12 14.6414.64 22 55.0955.09 16.0916.09 52.7652.76 15.3115.31 33 57.3257.32 16.1316.13 52.1552.15 15.0615.06 44 54.5354.53 15.5815.58 53.3653.36 14.2114.21 55 53.8753.87 16.3216.32 52.8752.87 15.3915.39

상기 표 8로부터, 집단 1, 2대상자들에 대한 피지분비 측정 실험에서, 피지는 화장료 처리 4주 후에 감소가 됨을 알 수 있는데, 이러한 피지분비 감소는 여드름 발생을 일으키는 피지를 감소시키는 모공의 축소 기능에 의한 것이다.From Table 8, it can be seen that in sebum secretion measurement experiments for population 1 and 2 subjects, sebum is reduced after 4 weeks of cosmetic treatment, such sebum secretion reduction function of pores to reduce sebum causing acne It is by.

이상의 설명으로부터 알 수 있는 바와 같이, 인돌-3 복합체를 함유하는 본 발명의 화장료 조성물은 피부에 대한 자극이 없으며, 피지의 분비를 감소시킬 수 있고, 여드름에 의한 피부 각질을 개선시킬 수 있으므로, 여드름 피부에 효과적이다.As can be seen from the above description, the cosmetic composition of the present invention containing the indole-3 complex has no irritation to the skin, can reduce the secretion of sebum, and can improve the skin keratin caused by acne, Effective for the skin

Claims (1)

조성물 총 중량에 대하여 인돌-3 아세틱애시드 0.0001~0.01중량, 카바마이드퍼옥사이드 5.0~15.0중량및 α-히드록시애시드 0.2~1.0중량로 이루어진 인돌-3 복합체를 함유하는 것을 특징으로 하는 여드름 피부용 화장료 조성물.Cosmetics for acne skin comprising an indole-3 complex consisting of 0.0001 to 0.01 weight of indole-3 acetic acid, 5.0 to 15.0 weight of carbamide peroxide, and 0.2 to 1.0 weight of α-hydroxy acid, based on the total weight of the composition Composition.
KR1019990036863A 1999-09-01 1999-09-01 Cosmetic compositions for the skin having pimples thereon KR20010025824A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019990036863A KR20010025824A (en) 1999-09-01 1999-09-01 Cosmetic compositions for the skin having pimples thereon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019990036863A KR20010025824A (en) 1999-09-01 1999-09-01 Cosmetic compositions for the skin having pimples thereon

Publications (1)

Publication Number Publication Date
KR20010025824A true KR20010025824A (en) 2001-04-06

Family

ID=19609642

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019990036863A KR20010025824A (en) 1999-09-01 1999-09-01 Cosmetic compositions for the skin having pimples thereon

Country Status (1)

Country Link
KR (1) KR20010025824A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009013162A (en) * 2007-06-29 2009-01-22 Welskin Co Ltd Photosenstive acne therapeutic agent, photosenstive acne therapeutic agent composition, kit for photodynamic acne therapy, photosensitive sebum secretion inhibitor, photosensitive sebum secretion inhibitor composition and kit for photodynamic sebum secretion inhibitor
KR101315133B1 (en) * 2011-12-12 2013-10-07 주식회사 웰스킨 Phamacetical composition containing indole-3-acetic acid for treatment of rosacea and kit for photodynamic therapy of rosacea containing the same
CN111150674A (en) * 2020-03-02 2020-05-15 上海新高姿化妆品有限公司 Acne removing composition with mild oil control function and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000628A1 (en) * 1981-08-27 1983-03-03 Bernstein, Joel, E. A method of treating acne vulgaris and composition containing carbamide peroxide
US4607101A (en) * 1981-08-27 1986-08-19 Jaye-Boern Laboratories, Inc. Method of treating acne vulgaris with a composition containing carbamide peroxide
JPH03188019A (en) * 1989-12-15 1991-08-16 Shiseido Co Ltd Testosterone-5alpha-reductase inhibitor
US5843998A (en) * 1997-06-30 1998-12-01 Song; Jin Skin blemish treatment

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000628A1 (en) * 1981-08-27 1983-03-03 Bernstein, Joel, E. A method of treating acne vulgaris and composition containing carbamide peroxide
US4607101A (en) * 1981-08-27 1986-08-19 Jaye-Boern Laboratories, Inc. Method of treating acne vulgaris with a composition containing carbamide peroxide
JPH03188019A (en) * 1989-12-15 1991-08-16 Shiseido Co Ltd Testosterone-5alpha-reductase inhibitor
US5843998A (en) * 1997-06-30 1998-12-01 Song; Jin Skin blemish treatment

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009013162A (en) * 2007-06-29 2009-01-22 Welskin Co Ltd Photosenstive acne therapeutic agent, photosenstive acne therapeutic agent composition, kit for photodynamic acne therapy, photosensitive sebum secretion inhibitor, photosensitive sebum secretion inhibitor composition and kit for photodynamic sebum secretion inhibitor
KR101315133B1 (en) * 2011-12-12 2013-10-07 주식회사 웰스킨 Phamacetical composition containing indole-3-acetic acid for treatment of rosacea and kit for photodynamic therapy of rosacea containing the same
CN111150674A (en) * 2020-03-02 2020-05-15 上海新高姿化妆品有限公司 Acne removing composition with mild oil control function and preparation method thereof

Similar Documents

Publication Publication Date Title
US6932963B2 (en) Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
EP0299756B1 (en) Anti-acne composition
EP0715852B1 (en) Use of hyaluronic acid or its salt to treat skin disease
US4593046A (en) Method of reducing skin irritation from benzoyl peroxide
JP4745608B2 (en) Skin treatment using phosphoric acid derivatives of electron transfer agents
US7125882B2 (en) Treatment of acne using alkonolamine compositions
JP4564471B2 (en) Composition suitable for external use
AU2002317053A1 (en) Dermal therapy using phosphate derivatives of electron transfer agents
US11090205B2 (en) Methods and compositions for treatment of skin conditions
JPH07277939A (en) Skin external preparation
CN108430587B (en) Personal care compositions comprising taurine, arginine, glycine
AU754420B2 (en) Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases
RU2126243C1 (en) Dermatological and cosmetic composition
US3663716A (en) Method of treating acne with benzyl alcohol
US20020176876A1 (en) Topical therapeutic skin care system
JPH01311014A (en) Antimicrobial skin drug for external use
KR20010025824A (en) Cosmetic compositions for the skin having pimples thereon
US20030165552A1 (en) Compositions and methods for delivery of skin cosmeceuticals
KR20000018910A (en) Composition for acne skin
KR20070006626A (en) Topical composition for transdermal administration
CN115919679A (en) Microemulsion preconcentration composition for inhibiting bacteria, removing acnes, promoting wound healing and reducing acne marks and preparation method and application thereof
RU2481845C2 (en) Stabilised topical composition possessing comedolytic and antibiotic action
JPS6028924A (en) External preparation for skin

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application